JelikaLite

medical devices

About

JelikaLite is a clinical-stage medical technology company based in New York, founded in 2019. The company specializes in pediatric neurological health, focusing on autism spectrum disorder (ASD). JelikaLite develops innovative, non-invasive therapeutic solutions designed to reduce autism symptoms in children, enhancing communication, speech, and social responsiveness while also reducing anxiety. The flagship product, Cognilum, is a home-based therapeutic system that combines a wearable medical device with an AI personalization platform. This system utilizes near-infrared light therapy and sensors to gather physical measurements, allowing the AI to tailor treatments to each child's specific needs. Cognilum is intended for children aged two to six years and aims to improve daily living skills and facilitate language learning. The system has received FDA Breakthrough Device Designation and has completed Phase 1 clinical trials, demonstrating safety and promising efficacy. JelikaLite's mission is to empower children with autism to lead fulfilling lives through innovative neurostimulation therapies.

Technologies

WordPress.org ShareThis Apache Mobile Friendly Vimeo Data Analytics IoT Micro Remote

Keywords

autism medical devices technology artificial intelligence health medical equipment manufacturing autism brain stimulation non-invasive therapy machine learning autism clinical trials non-invasive brain stimulation digital health personalized medicine autism symptom reduction wearable autism device autism intervention healthcare technology autism spectrum disorder brain stimulation device autism therapy device medical equipment and supplies manufacturing clinical trials photobiomodulation sensor data analysis autism treatment autism care innovation personalized ai platform d2c medical device development transcranial light therapy

Location

30 Wall St, New York, New York, United States, 10005

Related Companies

Companies in the same industry